Estonia -
estonio -
Ravimiamet
alendronic acid/colecalciferol zentiva tablett
zentiva k.s. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 12tk; 70mg+5600rÜ 2tk
Estonia -
estonio -
Ravimiamet
alendronic acid/colecalciferol mylan tablett
mylan pharmaceuticals limited - alendroonhape+kolekaltsiferool - tablett - 70mg+2800rÜ 12tk; 70mg+2800rÜ 4tk
Estonia -
estonio -
Ravimiamet
alendronic acid/colecalciferol teva tablett
teva pharma b.v. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 16tk; 70mg+5600rÜ 12tk; 70mg+5600rÜ 24tk; 70mg+5600rÜ 4tk; 70mg+5600rÜ 28tk
Estonia -
estonio -
Ravimiamet
alendronic acid/ colecalciferol sandoz tablett
sandoz pharmaceuticals d.d. - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 4tk; 70mg+5600rÜ 6tk; 70mg+5600rÜ 2tk; 70mg+5600rÜ 12tk
Estonia -
estonio -
Ravimiamet
vitol-140 süstelahus
interchemie werken de adelaar eesti aktsiaselts - retinool+tokoferool+kolekaltsiferool - süstelahus - 80000rÜ+20mg+40000rÜ 1ml 100ml 1tk
Estonia -
estonio -
Ravimiamet
alendronic acid/colecalciferol zentiva tablett
zentiva k.s. - alendroonhape+kolekaltsiferool - tablett - 70mg+2800rÜ 4tk; 70mg+2800rÜ 12tk
Estonia -
estonio -
Ravimiamet
vitamin ad3e bela-pharm süstelahus
bela-pharm gmbh & co. kg - retinool+tokoferool+kolekaltsiferool - süstelahus - 176,47mg+50mg+100mg 1ml 100ml 1tk; 176,47mg+50mg+100mg 1ml 100ml 6tk; 176,47mg+50mg+100mg 1ml 100ml 12tk
Estonia -
estonio -
Ravimiamet
alendronic acid/colecalciferol mylan tablett
mylan pharmaceuticals limited - alendroonhape+kolekaltsiferool - tablett - 70mg+5600rÜ 12tk
Unión Europea -
estonio -
EMA (European Medicines Agency)
roctavian
biomarin international limited - valoctocogene roxaparvovec - antihemorraagilised ained - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).
Unión Europea -
estonio -
EMA (European Medicines Agency)
vitekta
gilead sciences international ltd - elvitegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - vitekta manustamine koos ritonaviiriga võimendatud proteaasi inhibiitori ja teiste retroviiruste vastaste on näidustatud inimese-immuunpuudulikkuse viirus-1 (hiv-1) infektsiooni raviks täiskasvanutel, kes on nakatunud hiv-1 ilma teadaolevate seotud elvitegraviiri.